BON, ISABELLA
BON, ISABELLA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Personale tecnico amm.vo
Bon Isabella; Bonn I; BON I.
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
2024 Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P.
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.
2023 Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir
2022 Calza L, Legnani G, Fulgaro C, Verucchi G, Bon I, Lazzarotto T, Viale P
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir
2022 Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people
2022 Taglieri, Nevio; Bonfiglioli, Rachele; Bon, Isabella; Malosso, Pietro; Corovic, Andrej; Bruno, Matteo; Le, Elizabeth; Granozzi, Bianca; Palmerini, Tullio; Ghetti, Gabriele; Tamburello, Martina; Bruno, Antonio Giulio; Saia, Francesco; Tarkin, Jason M.; Rudd, James H. F.; Calza, Leonardo; Fanti, Stefano; Re, Maria Carla; Galié, Nazzareno
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir
2022 Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
2021 Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocale C.; Gaibani P.; Viale P.; Attard L.
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection.
2021 Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19
2021 Chiereghin A.; Zagari R.M.; Galli S.; Moroni A.; Gabrielli L.; Venturoli S.; Bon I.; Rossini G.; Saracino I.M.; Pavoni M.; Lafratta S.; Deni A.; Felici S.; Borghi M.; Guerra L.; Raumer L.; Lodi V.; Viale P.; Attard L.; Lazzarotto T.; Borgatti E.C.; Leone M.; Mancini R.; Petrisli E.; Turello G.; Gaibani P.; Vocale C.; Roncarati G.; Magnani S.; Fioro M.A.; Fava M.; Marzaduri A.; Di Felice G.; Caveduri F.
Restriction Factors expression decreases in HIV-1 patients after cART
2021 D'Urbano, Vanessa; Bertoldi, Alessia; Re, Maria Carla; De Crignis, Elisa; Tamburello, Martina; Primavera, Alessandra; Laginestra, Maria Antonella; Zanasi, Nicolò; Calza, Leonardo; Viale, Pier Luigi; Lazzarotto, Tiziana; Bon, Isabella; Gallinella, Giorgio
Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.
2021 Calza L, Colangeli V, Borderi M, Beci G, Esposito F, Bon I, Re MC, Viale P
Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir.
2021 Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P
Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine.
2021 Calza L, Borderi M, Colangeli V, Esposito F, Giglia M, Bon I, Re MC
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1
2020 Bertoldi A.; D'Urbano V.; Bon I.; Verbon A.; Rokx C.; Boucher C.; van Kampen J.J.A.; Gruters R.A.; Gallinella G.; Calza L.; Mahmoudi T.; De Crignis E.; Re M.C.
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke
2020 Pensato U.; Muccioli L.; Pasini E.; Tappata M.; Ferri L.; Volpi L.; Licchetta L.; Battaglia S.; Rossini G.; Bon I.; Re M.C.; Cirillo L.; Simonetti L.; Gramegna L.L.; Michelucci R.; Cortelli P.; Zini A.; Bisulli F.
HBsAg seroreversion in HBsAg-negative/HBcAb-positive patients with HIV infection treated with direct-acting antivirals for HCV: A retrospective study
2020 Guardigni V.; Granozzi B.; Badia L.; Galli S.; Bon I.; Verucchi G.
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy
2020 Calza L, Tamburello M, Borderi M, Colangeli V, Testi D, Amedeo A, Re MC, Bon I
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
2020 Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P.
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study.
2019 Calza L, di Pietro G, Colangeli V, Borderi, Zaghi I, Malosso P, Bon I, Re MC, Viale P
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
2019 Calza, Leonardo; Colangeli, Vincenzo; Borderi, Marco; Coladonato, Simona; Tazza, Beatrice; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain. | Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P. | 2024-01-01 | HIV MEDICINE | - | 1.01 Articolo in rivista | - |
| Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience. | Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P | 2023-01-01 | INTERNATIONAL JOURNAL OF STD & AIDS | - | 1.01 Articolo in rivista | - |
| Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir | Calza L, Legnani G, Fulgaro C, Verucchi G, Bon I, Lazzarotto T, Viale P | 2022-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | AIDS 2022.pdf |
| Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir | Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P | 2022-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | - |
| Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people | Taglieri, Nevio; Bonfiglioli, Rachele; Bon, Isabella; Malosso, Pietro; Corovic, Andrej; Bruno, Ma...tteo; Le, Elizabeth; Granozzi, Bianca; Palmerini, Tullio; Ghetti, Gabriele; Tamburello, Martina; Bruno, Antonio Giulio; Saia, Francesco; Tarkin, Jason M.; Rudd, James H. F.; Calza, Leonardo; Fanti, Stefano; Re, Maria Carla; Galié, Nazzareno | 2022-01-01 | JOURNAL OF NUCLEAR CARDIOLOGY | - | 1.01 Articolo in rivista | 12350_2020_2522_MOESM1_ESM.docx; 12350_2020_2522_MOESM2_ESM.pptx; s12350-020-02522-5.pdf |
| Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir | Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P | 2022-01-01 | AIDS | - | 1.01 Articolo in rivista | - |
| COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy | Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocal...e C.; Gaibani P.; Viale P.; Attard L. | 2021-01-01 | INFECTION | - | 1.01 Articolo in rivista | Infection 2021.pdf |
| COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. | Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P | 2021-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | - |
| Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 | Chiereghin A.; Zagari R.M.; Galli S.; Moroni A.; Gabrielli L.; Venturoli S.; Bon I.; Rossini G.; ...Saracino I.M.; Pavoni M.; Lafratta S.; Deni A.; Felici S.; Borghi M.; Guerra L.; Raumer L.; Lodi V.; Viale P.; Attard L.; Lazzarotto T.; Borgatti E.C.; Leone M.; Mancini R.; Petrisli E.; Turello G.; Gaibani P.; Vocale C.; Roncarati G.; Magnani S.; Fioro M.A.; Fava M.; Marzaduri A.; Di Felice G.; Caveduri F. | 2021-01-01 | FRONTIERS IN PUBLIC HEALTH | - | 1.01 Articolo in rivista | fpubh-08-620222.pdf |
| Restriction Factors expression decreases in HIV-1 patients after cART | D'Urbano, Vanessa; Bertoldi, Alessia; Re, Maria Carla; De Crignis, Elisa; Tamburello, Martina; Pr...imavera, Alessandra; Laginestra, Maria Antonella; Zanasi, Nicolò; Calza, Leonardo; Viale, Pier Luigi; Lazzarotto, Tiziana; Bon, Isabella; Gallinella, Giorgio | 2021-01-01 | NEW MICROBIOLOGICA | - | 1.01 Articolo in rivista | NewMicrobiologica D'Urbano 2021.pdf |
| Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome. | Calza L, Colangeli V, Borderi M, Beci G, Esposito F, Bon I, Re MC, Viale P | 2021-01-01 | INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
| Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir. | Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P | 2021-01-01 | AIDS RESEARCH AND HUMAN RETROVIRUSES | - | 1.01 Articolo in rivista | - |
| Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. | Calza L, Borderi M, Colangeli V, Esposito F, Giglia M, Bon I, Re MC | 2021-01-01 | AIDS RESEARCH AND HUMAN RETROVIRUSES | - | 1.01 Articolo in rivista | - |
| Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 | Bertoldi A.; D'Urbano V.; Bon I.; Verbon A.; Rokx C.; Boucher C.; van Kampen J.J.A.; Gruters R.A....; Gallinella G.; Calza L.; Mahmoudi T.; De Crignis E.; Re M.C. | 2020-01-01 | JOURNAL OF VIROLOGICAL METHODS | - | 1.01 Articolo in rivista | Bertoldi et al. 2020.pdf |
| Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke | Pensato U.; Muccioli L.; Pasini E.; Tappata M.; Ferri L.; Volpi L.; Licchetta L.; Battaglia S.; R...ossini G.; Bon I.; Re M.C.; Cirillo L.; Simonetti L.; Gramegna L.L.; Michelucci R.; Cortelli P.; Zini A.; Bisulli F. | 2020-01-01 | FRONTIERS IN NEUROLOGY | - | 1.01 Articolo in rivista | fneur-11-587226.pdf; Table_1.DOCX |
| HBsAg seroreversion in HBsAg-negative/HBcAb-positive patients with HIV infection treated with direct-acting antivirals for HCV: A retrospective study | Guardigni V.; Granozzi B.; Badia L.; Galli S.; Bon I.; Verucchi G. | 2020-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy | Calza L, Tamburello M, Borderi M, Colangeli V, Testi D, Amedeo A, Re MC, Bon I | 2020-01-01 | JOURNAL OF MEDICAL VIROLOGY | - | 1.01 Articolo in rivista | - |
| Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir | Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P. | 2020-01-01 | INFECTION | - | 1.01 Articolo in rivista | - |
| Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. | Calza L, di Pietro G, Colangeli V, Borderi, Zaghi I, Malosso P, Bon I, Re MC, Viale P | 2019-01-01 | NEW MICROBIOLOGICA | - | 1.01 Articolo in rivista | - |
| Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients | Calza, Leonardo; Colangeli, Vincenzo; Borderi, Marco; Coladonato, Simona; Tazza, Beatrice; Bon, I...sabella; Re, Maria Carla; Viale, Pierluigi | 2019-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |